Safe S.A. specializes in the design, manufacture and marketing of medical devices for spine surgery. The company offers implants and instruments in the range of SteriSpine (the first spinal arthrodesis system that is for single use and is sterile and totally traceable). The group's activity is organized around 2 areas: - direct and indirect sales of medical devices (Safe Orthopaedics): business carried out in France, Germany, the United Kingdom, the United States and South America; - subcontracted manufacturing services for orthopedic medical devices (Safe Medical).

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Market Cap	1L 1L 1L 1L 2L 1.38Cr 2L 14.35L 6L 70.26L 5L 5L 2.26Cr	P/E 2024 *	-	P/E 2025	-0.07x
Enterprise Value	1.32Cr 1.48Cr 1.23Cr 1.12Cr 2.11Cr 142.93Cr 2.13Cr 15Cr 5.8Cr 73Cr 5.57Cr 5.45Cr 234.48Cr	EV / Sales 2024	2.39x	EV / Sales 2025	2.47x
Free-Float	87.27%	Yield 2024 *	-	Yield 2025	-

30/06	Safe Group sharply improves its full-year results
29/06	Safe Orthopaedics SA Reports Earnings Results for the Full Year Ended December 31, 2025	CI
28/05	Safe And ABL Alpstein Sign Exclusive Distribution Agreement For SteriSpine Range In Peru	CI
28/05	Safe Group enters Peru with exclusive distribution agreement
16/03	Changes to the SAFE Board of Directors
17/12	Safe Orthopaedics Signs Exclusive Distribution Agreement for Spanish Market	MT
17/12	Safe Group Signs Strategic Distribution Agreement in Spain with Vortrom Biologics	CI
01/12	Safe Orthopaedics SA Reports Earnings Results for the Full Year Ended December 31, 2024	CI
28/25/28	Alert wrongly tagged to Safe SA withdrawn	RE
27/24/27	Safe Orthopaedics SA Reports Earnings Results for the Half Year Ended June 30, 2024	CI
09/24/09	The market burns its idols
05/24/05	Safe: wins its appeal against Neo Medical
28/23/28	Safe: audit initiated for a turnaround plan

22/12	SAFE, SPONSOR OF THE 12TH MAMMI INTERNATIONAL CONFERENCE IN ITALY	GL
17/12	SAFE SIGNS A STRATEGIC DISTRIBUTION AGREEMENT IN SPAIN WITH VORTROM BIOLOGICS	GL
17/12	SAFE SIGNS A STRATEGIC DISTRIBUTION AGREEMENT IN SPAIN WITH VORTROM BIOLOGICS	AQ
09/24/09	New bond financing agreement in a minimum amount of €3 million in anticipation of validation of the continuation plan	GL
24/23/24	Safe group announces the convocation of the Annual General Meeting of Shareholders to be held on December 15th 2023 and provides an update on the situation	AQ

08/09	SAFE : point sur l'audience du 7 septembre 2026 devant le Tribunal des activités économiques de Lyon
25/08	SAFE Group : point sur la suspension de cotation et sur la certification des comptes annuels 2025
30/06	Safe Group améliore nettement ses résultats annuels
28/05	Safe Group s'implante au Pérou avec un accord de distribution exclusif
28/04	Safe S A : Report de la publication des résultats annuels 2025 de SAFE Group

Manager	Title	Age	Since
Nicolas Papillon CEO	Chief Executive Officer	46	-
Thomas Droulout CTO	Chief Tech/Sci/R&D Officer	50	15/02/2010
François-Henri Reynaud DFI	Director of Finance/CFO	-	09/11/2017

Safe Orthopaedics Share Price Euronext Paris

Stocks

Medical Equipment, Supplies & Distribution

Valuation: Safe Orthopaedics

Latest news: Safe Orthopaedics

Press Releases: Safe Orthopaedics

News in other languages: Safe Orthopaedics

Quotes and Performance

Managers and Directors: Safe Orthopaedics

Medical Devices & Implants

Financials

Company Profile

Director	Title	Age	Since
Thomas Droulout BRD	Director/Board Member	50	-
François-Henri Reynaud BRD	Director/Board Member	-	26/11/2019
Ismaël Nujurally BRD	Director/Board Member	69	26/11/2019

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SAFE ORTHOPAEDICS	-0.79%	-8.36%	-	-	1L
ABBOTT LABORATORIES	+2.85%	-0.53%	-24.90%	+4.41%	17TCr
MEDTRONIC PLC	+1.52%	-1.96%	-10.85%	+15.23%	11TCr
STRYKER CORPORATION	+2.78%	+2.88%	-22.67%	+6.96%	11TCr
ESSILORLUXOTTICA	+1.19%	-1.10%	-47.66%	-11.35%	7.39TCr
CENCORA, INC.	+2.02%	+3.87%	+3.36%	+70.54%	5.9TCr
HOYA CORPORATION	+1.32%	+4.32%	+14.41%	+64.37%	5.13TCr
BECTON, DICKINSON AND COMPANY	+1.40%	-2.47%	-6.61%	-31.32%	4.82TCr
IDEXX LABORATORIES, INC.	+1.50%	-0.50%	-16.14%	+22.28%	4.08TCr
DEXCOM, INC.	+1.52%	+0.24%	+30.93%	+3.43%	3.22TCr
Average	+1.54%	-0.86%	-8.90%	+16.06%	7.67TCr
Weighted average by Cap.	+2.03%	-1.30%	-15.01%	+13.47%

	2024	2025
Net sales	50.41L 56.51L 46.96L 42.74L 80.49L 54Cr 81.08L 5.67Cr 2.21Cr 28Cr 2.12Cr 2.08Cr 89Cr	53.64L 60.13L 49.97L 45.48L 85.64L 58Cr 86.28L 6.04Cr 2.35Cr 30Cr 2.26Cr 2.21Cr 95Cr
Net income	-192.93Cr -216.27Cr -179.74Cr -163.57Cr -308.04Cr -21TCr -310.32Cr -2.17TCr -845Cr -11TCr -811.87Cr -794.35Cr -34TCr	-46.74L -52.39L -43.55L -39.63L -74.63L -50Cr -75.18L -5.26Cr -2.05Cr -26Cr -1.97Cr -1.92Cr -83Cr
Net Debt	1.15Cr 1.29Cr 1.07Cr 97.25L 1.83Cr 123.84Cr 1.85Cr 13Cr 5.02Cr 63Cr 4.83Cr 4.72Cr 203.16Cr	1.31Cr 1.47Cr 1.22Cr 1.11Cr 2.09Cr 141.55Cr 2.11Cr 15Cr 5.74Cr 72Cr 5.52Cr 5.4Cr 232.22Cr